Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
Actinium Pharmaceuticals
Actinium Pharmaceuticals
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Bellicum Pharmaceuticals
Roswell Park Cancer Institute
Nanfang Hospital, Southern Medical University
National Cancer Institute (NCI)
Virginia Commonwealth University